Essential Partners »

Aclaris Therapeutics shares owned by Essential Partners

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Essential Partners from 13F filings

Historical chart of Essential Partners investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Essential Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Essential Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $19 5 3.80
2025-12-31 $15 5 3.00

More positions owned by Essential Partners

Sprott Gold Convert to Physical Cef (PHYS)
Comfort Sys Usa Stock (FIX)
Nvidia Corporation Stock (NVDA)
Schwab Fundamental Int'l Broad Etf (FNDF)
iShares S&P 500 Etf (IVV)
Schwab Fundamental U.S. Broad Etf (FNDB)
Vanguard Short-Term USTS Etf (VGSH)
General Mtrs Stock (GM)
Ge Aerospace Stock (GE)
Merck & Co Stock (MRK)
Technipfmc Stock (FTI)
Ge Vernova Stock (GEV)
Teradyne Stock (TER)
Incyte Corp Stock (INCY)
Pnc Finl Svcs Group Stock (PNC)

View all positions for Essential Partners

Top funds holding Aclaris Therapeutics

BML Capital Management
Deep Track Capital
BlackRock
RA Capital Management
Vivo Capital
Vanguard Group
Vanguard Capital Management
Frazier Life Sciences Management
Rock Springs Capital Management
Decheng Capital
Adage Capital Partners GP
Balyasny Asset Management
Citadel Advisors
Morgan Stanley
Geode Capital Management

View all funds holding Aclaris Therapeutics